News about Consultants

PGWA to expand activities throughout the country to take up issues facing the pharmacy profession

PGWA to expand activities throughout the country to take up issues facing the pharmacy profession

The Pharmacy Graduates Welfare Association (PGWA), an organization of graduate pharmacists working under the Delhi government, is now chalking out an organizational expansion program to carry out across the country in the wake of multiple issues arising in various states with respect to the pharmacy profession and their welfare projects, it is learned

Consultants | 01/04/2022 | By Darshana

Global Pharmaceutical Quality Summit kick starts to share best practices in sustainable operations and quality excellence

Global Pharmaceutical Quality Summit kick starts to share best practices in sustainable operations and quality excellence

The event brought together leaders from the industry, regulatory agencies, academia and subject experts from India and across the globe to facilitate discussions on Making quality pharmaceuticals in India, sustainably, for the World.

Consultants | 26/02/2022 | By Darshana

Indian Pharmaceutical Alliance to host the seventh edition of the Global Pharmaceutical Quality Summit

Indian Pharmaceutical Alliance to host the seventh edition of the Global Pharmaceutical Quality Summit

The forum aims to bring manufacturers and regulators on a common platform to facilitate discussions resulting in meaningful and actionable outcomes in quality. The summit will feature more than 30 global leaders and regulators taking part in 15 sessions covering key aspects of manufacturing and quality with a view on sustainability

Consultants | 23/02/2022 | By Darshana

Federation of Asian Biotech Associations hosts special panel for innovation in pharma and biopharma sectors

Federation of Asian Biotech Associations hosts special panel for innovation in pharma and biopharma sectors

This two-days event will focus on exploring pharma and healthcare industry current position and their future in light of novel approaches and capabilities beyond the pandemic. BioAsia 2022 platform will be shared by leaders from the industry, academia, and governments from more than 70 countries to address the wide-ranging needs of the healthcare system

Consultants | 21/02/2022 | By Darshana

Future of pharma companies communication with doctors would be hybrid model: Survey

Future of pharma companies communication with doctors would be hybrid model: Survey

The future of pharmaceutical companies? communication with doctors would be a hybrid model of digital communication supported by physical connect, as almost 40 per cent of the doctors prefer the model, according to a recent survey on the trends in pharma communication post Covid-19 pandemic by Rediffusion Healthcare.

Consultants | 30/11/2021 | By Darshana

Glenmark Pharmaceuticals makes it to DJSI for fourth consecutive year

Glenmark Pharmaceuticals makes it to DJSI for fourth consecutive year

Glenmark Pharmaceuticals today announced that the company has been listed in the Dow Jones Sustainability Index (DJSI) under the category of emerging markets for the fourth consecutive year, the company notified via a statement

Consultants | 17/11/2021 | By Darshana

Fidelity Health Services to expand markets globally to offer pharmacovigilance services

Fidelity Health Services to expand markets globally to offer pharmacovigilance services

Besides catering to five pharmaceutical companies and a few global CROs as their outsourcing partner for pharmacovigilance services, the company has been offering its end-to-end services for the last 5 years to one of the top generic pharmaceutical companies, empowering it to market highly valued products in 30 global markets

Consultants | 01/10/2021 | By Darshana

TB Alliance and Lupin partner to manufacture anti-TB drug pretomanid

TB Alliance and Lupin partner to manufacture anti-TB drug pretomanid

The TB Alliance has granted Lupin a non-exclusive license to manufacture the anti-TB drug pretomanid as part of the three-drug BPaL regimen. Lupin intends to commercialise the anti-tuberculosis (TB) medicine in approximately 140 countries and territories

Consultants | 07/09/2021 | By Darshana

Centrient Pharmaceuticals completes acquisition of Astral SteriTech

Centrient Pharmaceuticals completes acquisition of Astral SteriTech

With the addition of Astral SteriTech's semi-synthetic cephalosporin and semi-synthetic penicillin sterile injectable finished dosage forms to Centrient's product portfolio, the company can now further meet the needs of customers and reach more patients with its critical life-saving medicine

Consultants | 03/09/2021 | By Darshana

Novartis secures approval in China for Cosentyx

Novartis secures approval in China for Cosentyx

Novartis has announced that the China National Medical Products Administration (NMPA) has further approved Cosentyx for the treatment of moderate-to-severe plaque psoriasis in paediatric patients

Consultants | 19/08/2021 | By Darshana

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology